Policy & Research
Shaping bipartisan public policy
AMMA's policy priorities focus on creating a fair and competitive environment for domestic producers — ensuring a secure and reliable supply chain for critical medical supplies.
Submissions, Letters & Research
Regulatory comments, open letters & white papers
Written Submission – Investigation No. 332-609, Effects on the U.S. Economy of Revoking China’s Permanent Normal Trade Relations Status
May 28, 2026
Comments on Advance Notice of Proposed Rulemaking – Medicare Program; Ensuring Safety Through Domestic Security with Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals (CMS-1516-ANPRM)
May 28, 2026
Comments of the American Medical Manufacturers Association on the Initiation of Section 301 Investigations: Acts, Policies, and Practices of Certain Economies Relating to Structural Excess Capacity and Production in Manufacturing Sectors (Docket No. USTR-2026-0067)
May 28, 2026
Comments of the American Medical Manufacturers Association on the Initiation of Section 301 Investigations of Acts, Policies, and Practices of Various Economies Related to the Failure to Impose and Effectively Enforce a Prohibition on the Importation of Goods Produced With Forced Labor (Docket No. USTR-2026-0133)
May 28, 2026
AMMA Response to Request for Comment on Section 232 Investigation of Imports of PPE
Nov 6, 2025
AMMA Congressional Open Letter 2025
Jan 23, 2025
AMMA Administration Open Letter 2025
Jan 23, 2025
AMMA Public USTR Comments on Section 301 Tariffs
Jul 1, 2024
AMMA 301 Modifications Letter - REDACTED (1)
AMMA White Paper: The State of the PPE Industry in the U.S.
Apr 24, 2024
A Reshoring Movement Spurred by the Pandemic As supply chains fractured in 2020, U.S. companies and buyers quickly realized that the predominant outsourcing of entire industries and product groupings might not be the…
Administration Open Letter
Feb 7, 2024
Administration Open Letter
Congressional Open Letter
Feb 6, 2024
Click to read the letter
115+ Organizations Call on Congress to Reauthorize PAHPA
Dec 28, 2023
S. Senator Bill Cassidy, M.D. (R-LA), ranking member of the Senate Health, Education, Labor and Pensions (HELP) Committee, released a statement highlighting the 137 organizations who have called on Congress to…
AMERICA’S PPE OPPORTUNITY
Oct 30, 2023
BUILDING SELF-RELIANCE THROUGH DOMESTIC PPE PRODUCTION The COVID-19 Pandemic exposed the USA’s reliance on foreign manufacturing of essential PPE. Before the pandemic, 90%+ PPE supplies were manufactured in Southeast…
Open Letter: Three Years Later, Substantial Work Remains to Strengthen America's Domestic PPE Supply Chain
Oct 25, 2023
A Bipartisan Commitment to America's Resilience
Oct 25, 2023
A dedicated White House Office of Pandemic Preparedness is necessary and a strategic imperative for the United States. That’s why AMMA greets today’s announcement with such hope and optimism. We hope this office works…
Memo of Findings
Oct 25, 2023
Domestic sourcing strategy brings balance to healthcare provider supply chains
Oct 25, 2023
4 Ways USAID Could Play a Critical Role in Projecting US Power Through American Manufacturing
Oct 25, 2023
Away They Go - A Bipartisan Senate Delegation Heads to China
Oct 25, 2023
Takeaway: We urge our leaders to protect America’s ability to remain competitive and resilient in the face of public health challenges Background: Senate Majority Leader Chuck Schumer will lead a bipartisan delegation…